BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20939027)

  • 1. Projecting health-care expenditure for Switzerland: further evidence against the 'red-herring' hypothesis.
    Colombier C; Weber W
    Int J Health Plann Manage; 2011; 26(3):246-63. PubMed ID: 20939027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care costs in the last year of life--the Dutch experience.
    Polder JJ; Barendregt JJ; van Oers H
    Soc Sci Med; 2006 Oct; 63(7):1720-31. PubMed ID: 16781037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population ageing and health care expenditure: a school of 'red herrings'?
    Werblow A; Felder S; Zweifel P
    Health Econ; 2007 Oct; 16(10):1109-26. PubMed ID: 17311357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
    Seshamani M; Gray A
    Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging, health expenditure, proximity to death, and income in Finland.
    Häkkinen U; Martikainen P; Noro A; Nihtilä E; Peltola M
    Health Econ Policy Law; 2008 Apr; 3(Pt 2):165-95. PubMed ID: 18634626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings.
    Wong A; van Baal PH; Boshuizen HC; Polder JJ
    Health Econ; 2011 Apr; 20(4):379-400. PubMed ID: 20232289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying.
    Breyer F; Felder S
    Health Policy; 2006 Jan; 75(2):178-86. PubMed ID: 15893848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of population ageing on future Danish drug expenditure.
    Kildemoes HW; Christiansen T; Gyrd-Hansen D; Kristiansen IS; Andersen M
    Health Policy; 2006 Feb; 75(3):298-311. PubMed ID: 16399170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure.
    Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Wilson N
    N Z Med J; 2014 May; 127(1393):12-25. PubMed ID: 24816953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do red herrings swim in circles? Controlling for the endogeneity of time to death.
    Felder S; Werblow A; Zweifel P
    J Health Econ; 2010 Mar; 29(2):205-12. PubMed ID: 20022392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of in-patient care in Western Australia in the last years of life: a population-based data linkage study.
    Moorin RE; Holman CD
    Health Policy; 2008 Mar; 85(3):380-90. PubMed ID: 17913279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ageing and health-care expenditure: the red herring argument revisited.
    Seshamani M; Gray A
    Health Econ; 2004 Apr; 13(4):303-14. PubMed ID: 15067669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to include time to death? The future of health care expenditure predictions.
    Stearns SC; Norton EC
    Health Econ; 2004 Apr; 13(4):315-27. PubMed ID: 15067670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public healthcare expenditure in Spain: measuring the impact of driving factors.
    Blanco-Moreno Á; Urbanos-Garrido RM; Thuissard-Vasallo IJ
    Health Policy; 2013 Jun; 111(1):34-42. PubMed ID: 23597871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of the effects of age and time to death on hospital costs.
    Seshamani M; Gray AM
    J Health Econ; 2004 Mar; 23(2):217-35. PubMed ID: 15019753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hong Kong's health spending projections through 2033.
    Leung GM; Tin KY; Chan WS
    Health Policy; 2007 Apr; 81(1):93-101. PubMed ID: 16806563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ageing of population and health care expenditure: a red herring?
    Zweifel P; Felder S; Meiers M
    Health Econ; 1999 Sep; 8(6):485-96. PubMed ID: 10544314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of demographic changes on health care expenditure in Germany: an analysis considering the expenditures of decedents].
    Gandjour A; Ihle P; Schubert I
    Gesundheitswesen; 2008 Feb; 70(2):77-80. PubMed ID: 18348096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.